| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.01 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |